Wacoal Holdings Corp. (WACLY)

Sage Therapeutics Revenue

In the fiscal year ending March 31, 2025, Wacoal Holdings had annual revenue of 173.90B JPY, down -7.11%. Wacoal Holdings had revenue of 40.36B in the quarter ending March 31, 2025, a decrease of -11.88%.

• Revenue: 173.90B JPY
• Revenue Growth: -7.11%
• P/S Ratio: 1.70
• Revenue / Employee: 10.78M JPY
• Employees: 16,124
• Market Cap: 1.98B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	173.90B	-13.31B	-7.11%
Mar 31, 2024	187.21B	-1.38B	-0.73%
Mar 31, 2023	188.59B	15.73B	9.10%
Mar 31, 2022	172.86B	20.66B	13.57%
Mar 31, 2021	152.20B	-34.56B	-18.50%